| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.306 | 5.471 | 9.194 | 27.445 | 94.012 | 102.908 | 158.420 | 190.181 | 205.483 | 186.043 |
| Total Income - EUR | 2.306 | 5.471 | 13.035 | 40.341 | 107.447 | 143.340 | 178.729 | 211.218 | 227.476 | 209.318 |
| Total Expenses - EUR | 239 | 2.930 | 9.175 | 39.620 | 56.415 | 88.512 | 112.918 | 120.601 | 120.828 | 134.215 |
| Gross Profit/Loss - EUR | 2.067 | 2.541 | 3.860 | 721 | 51.032 | 54.828 | 65.811 | 90.617 | 106.648 | 75.104 |
| Net Profit/Loss - EUR | 1.998 | 2.432 | 3.768 | 447 | 50.092 | 54.125 | 64.401 | 88.747 | 104.902 | 63.276 |
| Employees | 0 | 1 | 1 | 2 | 6 | 6 | 6 | 6 | 4 | 5 |
Check the financial reports for the company - Alclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 899 | 890 | 23.860 | 319.670 | 386.049 | 338.621 | 284.016 | 237.655 | 189.835 | 143.413 |
| Current Assets | 6.612 | 9.590 | 295.252 | 81.037 | 119.329 | 62.082 | 111.924 | 123.264 | 249.602 | 344.826 |
| Inventories | 0 | 0 | 3.693 | 3.957 | 3.555 | 0 | 0 | 885 | 809 | 0 |
| Receivables | 495 | 2.605 | 283.905 | 8.075 | 9.549 | 8.533 | 7.501 | 10.383 | 3.458 | 7.377 |
| Cash | 6.117 | 6.984 | 7.655 | 69.005 | 106.226 | 53.549 | 104.422 | 111.996 | 245.335 | 337.449 |
| Shareholders Funds | 7.379 | 9.735 | 13.343 | 13.544 | 63.374 | 116.111 | 137.506 | 125.291 | 229.812 | 63.329 |
| Social Capital | 45 | 45 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 132 | 744 | 121.141 | 220.174 | 288.830 | 168.925 | 165.631 | 162.901 | 156.922 | 392.604 |
| Income in Advance | 0 | 0 | 184.629 | 166.988 | 153.174 | 115.668 | 92.803 | 72.727 | 52.703 | 32.306 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Alclinic Srl